A prospective cohort study of Yangyin moisturizing ointment to intervene in patients with psoriasis vulgaris recurrence
- Conditions
- psoriasis
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion criteria for patients with psoriasis
(1) Meet the diagnostic criteria for plaque psoriasis vulgaris;
(2) 18 years old< age = 70 years old;
(3) Standardized injection of secukinumab injection for more than 12 weeks, 4~8 weeks after the last injection, and the willingness to stop the drug;
(4) PGA score =1, BSA =3%;
(5) Signed informed consent and willing to accept follow-up. Inclusion Criteria for Healthy Subjects.
Healthy control group: healthy subjects who will visit the China Academy of Chinese Medical Sciences from January 1, 2024 to November 1, 2026 The inclusion criteria are as follows:
(1) 18 years old< age = 70 years old;
(2) Persons with a physical examination (without a clear diagnosis of disease);
(3) Sign the informed consent form.
Exclusion criteria for patients with psoriasis
(1) Pregnant, planning pregnancy and lactating women;
(2) Systemic glucocorticoids, immunosuppressants, and retinoids within 4 weeks;
(3) Patients with severe liver and kidney insufficiency;
(4) Patients with severe mental illness;
(5) Participated in other clinical trials in the past three months.
Exclusion criteria for healthy subjects
(1) Pregnant, planning pregnancy and lactating women;
(2) Participated in other clinical trials in the past three months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method